Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice

Laboratory Investigation

Volumn 91, Issue 4, 2011, Pages 627-641

  Piconese, Silvia ^a   Costanza, Massimo ^b   Musio, Silvia ^b   Tripodo, Claudio ^c   Poliani, Pietro L ^d   Gri, Giorgia ^e   Burocchi, Alessia ^a   Pittoni, Paola ^a   Gorzanelli, Andrea ^a   Colombo, Mario P ^a   Pedotti, Rosetta ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

Author keywords

C kit mutations; experimental autoimmune encephalomyelitis; granulocytes; mast cells

Indexed keywords

ANTIGEN; IMMUNOLOGICAL ADJUVANT; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PERTUSSIS TOXIN; STEM CELL FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GRANULOCYTE; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MAST CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; BONE MARROW CELLS; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; GRANULOCYTES; IMMUNIZATION; MAST CELLS; MICE; MICE, INBRED C57BL; MUTATION; MYELIN SHEATH; PEPTIDE FRAGMENTS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 79953173306     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.3     Document Type: Article

References (73)

1. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-142. (Pubitemid 40268194)
2. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008;9:1215-1223.
3. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev 2008;8:478-486. (Pubitemid 351733419)
4. Kawakami T. A crucial door to the mast cell mystery knocked in. J Immunol 2009;183:6861-6862.
5. Chen R, Ning G, Zhao ML, et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001;108:1151-1158. (Pubitemid 32995373)
6. Lee DM, Friend DS, Gurish MF, et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297: 1689-1692. (Pubitemid 35000781)
7. Hochegger K, Siebenhaar F, Vielhauer V, et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur J Immunol 2005;35:3074-3082. (Pubitemid 41568074)
8. Kanamaru Y, Scandiuzzi L, Essig M, et al. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J Immunol 2006;176:5607-5615.
9. Zhou JS, Xing W, Friend DS, et al. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med 2007;204: 2797-2802. (Pubitemid 350179550)
10. Pedotti R, De Voss JJ, Steinman L, et al. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 2003;24:479-484. (Pubitemid 37088150)
11. Ibrahim MZ, Reder AT, Lawand R, et al. The mast cells of the multiple sclerosis brain. J Neuroimmunol 1996;70:131-138. (Pubitemid 26345921)
12. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol Scand 1974;50:611-618.
13. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002;8:500-508. (Pubitemid 34546753)
14. Couturier N, Zappulla JP, Lauwers-Cances V, et al. Mast cell transcripts are increased within and outside multiple sclerosis lesions. J Neuroimmunol 2008;195:176-185.
15. Rozniecki JJ, Hauser SL, Stein M, et al. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1995;37:63-66.
16. Secor VH, Secor WE, Gutekunst CA, et al. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000;191:813-822.
17. Robbie-Ryan M, Tanzola MB, Secor VH, et al. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 2003;170:1630-1634. (Pubitemid 36197375)
18. Tanzola MB, Robbie-Ryan M, Gutekunst CA, et al. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 2003;171: 4385-4391. (Pubitemid 37238717)
19. Piconese S, Gri G, Tripodo C, et al. Mast cells counteract regulatory Tcell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009;114:2639-2648.
20. Sayed BA, Christy AL, Walker ME, et al. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol 2010;184:6891-6900.
21. Bennett JL, Blanchet MR, Zhao L, et al. Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol 2009;182:5507-5514.
22. Stelekati E, Bahri R, D'Orlando O, et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009;31:665-676.
23. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000;192:455-462. (Pubitemid 30629171)
24. Norman MU, Hwang J, Hulliger S, et al. Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am J Pathol 2008;172:1638-1649. (Pubitemid 351793355)
25. Yang K, Vega JL, Hadzipasic M, et al. Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. J Autoimmun 2009;32:94-103.
26. Gri G, Piconese S, Frossi B, et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008;29:771-781.
27. Piddlesden SJ, Storch MK, Hibbs M, et al. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 1994;152:5477-5484.
28. Musio S, Gallo B, Scabeni S, et al. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol 2006;176:17-26. (Pubitemid 43023244)
29. Grimbaldeston MA, Chen CC, Piliponsky AM, et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167:835-848. (Pubitemid 41216366)
30. Nigrovic PA, Gray DH, Jones T, et al. Genetic inversion in mast celldeficient (W(sh)) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol 2008;173:1693-1701.
31. Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 1995;25:1951-1959.
32. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006;442:997-1002. (Pubitemid 44330250)
33. Grimbaldeston MA, Nakae S, Kalesnikoff J, et al. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007;8:1095-1104. (Pubitemid 47423757)
34. Villa I, Skokos D, Tkaczyk C, et al. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology 2001;102:165-172. (Pubitemid 32217508)
35. Yoshikawa T, Imada T, Nakakubo H, et al. Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology 2001;104:333-340. (Pubitemid 33064459)
36. Gounaris E, Blatner NR, Dennis K, et al. T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 2009;69:5490-5497.
37. de Vries VC, Wasiuk A, Bennett KA, et al. Mast cell degranulation breaks peripheral tolerance. Am J Transplant 2009;9:2270-2280.
38. Gregory GD, Robbie-Ryan M, Secor VH, et al. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur J Immunol 2005;35:3478-3486. (Pubitemid 43025529)
39. Wolters PJ, Mallen-St Clair J, Lewis CC, et al. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy 2005;35:82-88. (Pubitemid 40188275)
40. Kroenke MA, Carlson TJ, Andjelkovic AV, et al. IL-12- and IL-23- modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008;205:1535-1541. (Pubitemid 351962016)
41. McColl SR, Staykova MA, Wozniak A, et al. Treatment with antigranulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol 1998;161: 6421-6426. (Pubitemid 28536020)
42. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage in mouse bone marrow: RB6-8C5 mAb to granulocytedifferentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 1993;151:2399-2404.
43. Mildner A, Djukic M, Garbe D, et al. Ly-6G+CCR2- myeloid cells rather than Ly-6ChighCCR2+ monocytes are required for the control of bacterial infection in the central nervous system. J Immunol 2008;181:2713-2722.
44. Pittoni P, Piconese S, Tripodo C, et al. Tumor-intrinsic and extrinsic roles of c-Kit in cancer: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene; advance online publication, 8 November 2010; doi:10.1038/onc.2010.494
45. Krishnamoorthy N, Oriss TB, Paglia M, et al. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med 2008;14:565-573. (Pubitemid 351655220)
46. Borg C, Terme M, Taieb J, et al. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J Clin Invest 2004;114:379-388. (Pubitemid 39071610)
47. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 2006;12:214-219. (Pubitemid 43214748)
48. Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protoc 2006;1:1810-1819. (Pubitemid 46773300)
49. Chan JC, Knudson O, Wu F, et al. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci USA 2005;102:785-790. (Pubitemid 40282743)
50. Platten M, Youssef S, Hur EM, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 2009;106: 14948-14953.
51. Shelley O, Murphy T, Lederer JA, et al. Mast cells and resistance to peritoneal sepsis after burn injury. Shock 2003;19:513-518.
52. Piliponsky AM, Chen CC, Grimbaldeston MA, et al. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 2010;176:926-938.
53. Ohtsu H, Tanaka S, Terui T, et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001;502:53-56. (Pubitemid 32722059)
54. Lapilla M, Gallo B, Martinello M, et al. Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation. J Leukoc Biol 2011;89:259-267.
55. Yokote H, Miyake S, Croxford JL, et al. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 2008;173:1714-1723.
56. Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009;31:185-205.
57. Poliak S, Mor F, Conlon P, et al. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitaryadrenal axis and the immune system. J Immunol 1997;158:5751-5756. (Pubitemid 127483980)
58. Theoharides TC, Konstantinidou AD. Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci 2007;12:1615-1628.
59. Zhu B, Bando Y, Xiao S, et al. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 2007;179:5228-5237.
60. King IL, Dickendesher TL, Segal BM. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009;113:3190-3197.
61. Steinman L. A rush to judgment on Th17. J Exp Med 2008;205: 1517-1522. (Pubitemid 351962013)
62. Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6- regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009;10:514-523.
63. Jager A, Dardalhon V, Sobel RA, et al. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009;183:7169-7177.
64. Sayed BA, Christy A, Quirion MR, et al. The master switch: the role of mast cells in autoimmunity and tolerance. Ann Rev Immunol 2008;26:705-739. (Pubitemid 351600390)
65. Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009;206:1653-1660.
66. Brenner T, Soffer D, Shalit M, et al. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci 1994;122:210-213. (Pubitemid 24097271)
67. Letourneau R, Rozniecki JJ, Dimitriadou V, et al. Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis. J Neuroimmunol 2003;145:18-26. (Pubitemid 37485964)
68. Waskow C, Rodewald HR. Lymphocyte development in neonatal and adult c-Kit-deficient (c-KitW/W) mice. Adv Exp Med Biol 2002;512:1-10. (Pubitemid 35335184)
69. Piconese S, Pittoni P, Burocchi A, et al. A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2. Eur J Immunol 2010;40:2902-2913.
70. O'Connor RA, Anderton SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol 2008; 193:1-11.
71. Nautiyal KM, Ribeiro AC, Pfaff DW, et al. Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci USA 2008;105:18053-18057.
72. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 2010;30:689-702.
73. Theoharides TC, Rozniecki JJ, Sahagian G, et al. Impact of stress and mast cells on brain metastases. J Neuroimmunol 2008;205:1-7.